Clinical Trials and the African Person

Ike V. Iyioke, Ph.D. (2015) Michigan State University, has backgrounds in philosophy, international relations, journalism, and teaching. He has taught healthcare ethics, business ethics, and African philosophy. A MacArthur Foundation/SSRC Fellow, his career has included print journalism and university administration.

• PrefaceAcknowledgementsList of FiguresList of Abbreviations/TermsIntroductionPart 1: Clinical Trials1 Who is Responsible for Human Subjects (When Experiments Travel)?1.1 Introduction1.2 Experimentation with Human Subjects: A Selective Rehash1.2.1 Burroughs Wellcome (Now GlaxoSmithKline) Experiments1.2.2 Tuskegee Syphilis Study (1932–1972)1.2.3 Nuremberg Experiments1.2.4 Radiation Experiments1.2.5 Mustard gas Experiments1.2.6 Thalidomide1.2.7 Henry Beecher Report1.2.8 Jewish Chronic Disease Hospital and Willowbrook Tests1.3 Emergence of Research Ethics Codes1.4 Outsourcing of Clinical Trials1.5 Trovan Test Case1.6 Concluding Thoughts2 Transgenic Mosquitoes Project as Model2.1 Introduction2.2 Some Preliminaries2.3 The GMM Model2.4 GMM Model and Biodiversity2.5 Environmental Ethics and Bioethics2.6 Concluding ThoughtsPart 2: Responsibility3 Being Responsible3.1 Introduction3.2 Understanding Responsibility3.3 Responsibility as a Virtue3.4 Corporate Responsibility3.5 Concluding ThoughtsPart 3: Personhood4 Re-Conceiving Responsibility: A Role For Personhood in African Thought4.1 Introduction4.2 The ‘African Man’4.3 African vs. Euro-American Personhood4.4 African Personhood and Bioethics4.5 Summary4.6 The Die is Cast4.7 Concluding Thoughts4.8 Study Limitations/Directions for Future StudiesBibiliographyIndex